Guggenheim Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $617K | Sell |
2,038
-164
| -7% | -$49.6K | ﹤0.01% | 1074 |
|
|
2025
Q1 | $729K | Sell |
2,202
-466
| -17% | -$154K | 0.01% | 1023 |
|
|
2024
Q4 | $823K | Sell |
2,668
-978
| -27% | -$302K | 0.01% | 1000 |
|
|
2024
Q3 | $774K | Buy |
3,646
+311
| +9% | +$66K | 0.01% | 1217 |
|
|
2024
Q2 | $934K | Buy |
3,335
+365
| +12% | +$102K | 0.01% | 1154 |
|
|
2024
Q1 | $793K | Sell |
2,970
-451
| -13% | -$120K | 0.01% | 1287 |
|
|
2023
Q4 | $792K | Buy |
3,421
+284
| +9% | +$65.7K | 0.01% | 1264 |
|
|
2023
Q3 | $458K | Buy |
3,137
+431
| +16% | +$62.9K | ﹤0.01% | 1466 |
|
|
2023
Q2 | $625K | Sell |
2,706
-431
| -14% | -$99.6K | ﹤0.01% | 1358 |
|
|
2023
Q1 | $760K | Buy |
+3,137
| New | +$760K | 0.01% | 1303 |
|
|
2019
Q4 | – | Sell |
-16,064
| Closed | -$1.39M | – | 2117 |
|
|
2019
Q3 | $1.39M | Sell |
16,064
-1,043
| -6% | -$89.9K | 0.01% | 1167 |
|
|
2019
Q2 | $1.79M | Buy |
17,107
+926
| +6% | +$97.1K | 0.01% | 1104 |
|
|
2019
Q1 | $2.03M | Sell |
16,181
-1,622
| -9% | -$203K | 0.02% | 1065 |
|
|
2018
Q4 | $2.01M | Buy |
+17,803
| New | +$2.01M | 0.02% | 1037 |
|
|
2015
Q3 | – | Sell |
-341
| Closed | -$27K | – | 3011 |
|
|
2015
Q2 | $27K | Buy |
+341
| New | +$27K | ﹤0.01% | 2984 |
|